The change in the atrial fibrillation type as a prognosis marker in a community study: Long-term data from AFBAR (Atrial Fibrillation in the BARbanza) study

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2146-2152

  Vidal Perez, Rafael ^a   Otero Raviña, Fernando ^b   Lado López, Manuel ^c   Turrado Turrado, Victorino ^d   Rodríguez Moldes, Esperanza ^e   Gómez Vázquez, José L ^f   De Frutos De Marcos, Concepción ^g   De Blas Abad, Paula ^h   Besada Gesto, Ricardo ⁱ   Gonzalez Juanatey, José Ramón ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b SERGAS   (Spain)

^c Centro de Salud de Vite SERGAS   (Spain)

^d Centro de Salud Concepción Arenal   (Spain)

^e Centro de Salud Os Mallos   (Spain)

^f Centro de Saúde de Ribeira   (Spain)

^g Centro de Saúde de Padrón   (Spain)

^h Centro de Saúde de Porto Do Son   (Spain)

ⁱ Centro de Saúde de Rianxo   (Spain)

Author keywords

Atrial fibrillation; Primary care; Prognosis

Indexed keywords

ACUTE HEART INFARCTION; AGED; ANEMIA; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEALTH STATUS; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEW ONSET HEART ATRIUM FIBRILLATION; OVERALL SURVIVAL; PAROXYSMAL HEART ATRIUM FIBRILLATION; PERMANENT HEART ATRIUM FIBRILLATION; PERSISTENT HEART ATRIUM FIBRILLATION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; SPAIN; SUDDEN CARDIAC DEATH; ATRIAL FIBRILLATION; CLINICAL TRIAL; DISEASE COURSE; EPIDEMIOLOGY; HOSPITALIZATION; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; TIME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS;

EID: 84885665506     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.261     Document Type: Article

References (32)

1. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention. The Anticoagulation and Risk Factors Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
2. P.A. Wolf, E.J. Benajamin, and A.J. Belanguer Secular trends in prevalence of atrial fibrillation: the Framingham study Am Heart J 131 1996 790 795
3. Y. Miyasaka, M.E. Barnes, and B.J. Gersh Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
4. A.D. Krahn, J. Manfreda, R. Tate, F. Mathewson, and T. Cuddy Natural history of atrial fibrillation; incidence, risk factors and prognosis in the Manitoba follow-up study Am J Med 98 May 1995 476 484
5. W.B. Kannel, P.A. Wolf, E.J. Benjamin, and D. Levy Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 82 1998 2N 9N
6. W.M. Feinberg, J.L. Blackshear, and A. Laupasis Prevalence, age distribution and gender in patients with atrial fibrillation: analysis and implications Arch Intern Med 155 1995 469 473
7. P.T. Onundarson, G. Thorgeirsson, E. Jonmundsson, N. Sigfusson, and T. Hardarson Chronic atrial fibrillation-epidemiologic features and 14 year follow-up: a case control study Eur Heart J 8 1987 521 527
8. S. Stewart, N. Murphy, A. Walker, A. McGuire, and J.J.V. McMurray Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK Heart 90 2004 286 292
9. N.F. Murphy, C.R. Simpson, and P.S. Jhund A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland Heart 93 2007 606 612
10. Lance Ceresne, and Ross Upshur Atrial fibrillation in primary care practice: prevalence and management BMC Fam Pract 3 2002 11
11. A. García-Castelo, J. García-Seara, and F. Otero-Raviña Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study) Int J Cardiol 153 2011 68 73
12. E. Abu-Assi, F. Otero-Raviña, and G. Allut Vidal Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation Int J Cardiol 166 1 Jun 5 2013 205 209
13. F.N. Brand, R.D. Abbott, W.B. Kannel, and P.A. Wolf Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham study JAMA 254 1985 3449 3453
14. S.L. Kopecky, B.J. Gersh, and M.D. McGoon The natural history of lone atrial fibrillation. A population-based study over three decades N Engl J Med 317 1987 669 674
15. S. Levy, M. Mareek, and P. Coumel Characterization of different subsets of atrial fibrillation in general practice in France; the ALFA study: the College of French cardiologists Circulation 99 1999 3028 3035
16. Renate B. Schnabel, Lisa M. Sullivan, Daniel Levy, Michael J. Pencina, Joseph M. Massaro, and Ralph B. D'Agostino Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study Lancet 373 2009 739 745
17. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D' Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 1994 840 844
18. R. Vidal-Perez, F. Otero-Raviña, and M. Franco Determinants of cardiovascular mortality in a cohort of primary care patients with chronic ischemic heart disease. BARBANZA Ischemic Heart Disease (BARIHD) study Int J Cardiol 167 2 Jul 31 2013 442 450
19. J.Y. Le Heuzey, G. Breithardt, and J. Camm The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation Am J Cardiol 105 5 Mar 1 2010 687 693
20. T.J. Wang, M. Larson, and D. Levy Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925
21. P.E. Carson, G.R. Johnson, and W.B. Dunkman For the V-HEFT VA cooperative studies group. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-HEFT studies Circulation 87 1993 VI102 VI110
22. V. Barrios, A. Calderón, C. Escobar, and M. de la Figuera Primary Care Group in the Clinical Cardiology Section of the Spanish Society of Cardiology. Patients with atrial fibrillation in a primary care setting: Val-FAAP study Rev Esp Cardiol 65 2012 47 53
23. D.D. McManus, M. Rienstra, and E.J. Benjamin An update on the prognosis of patients with atrial fibrillation Circulation 126 10 2012 e143 e146
24. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
25. G.J. Hankey Long-term outcome after ischaemic stroke/transient ischaemic attack Cerebrovasc Dis 16 Suppl. 1 2003 14 19
26. D.T. Ko, D.A. Alter, and P.C. Austin Life expectancy after an index hospitalization for patients with heart failure: a population-based study Am Heart J 155 2008 324 331
27. A. Varela-Roman, J.R. Gonzalez-Juanatey, and P. Basante Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction Heart 88 2002 249 254
28. J.A. Lardizabal, and P.C. Deedwania Atrial fibrillation in heart failure Med Clin North Am 96 5 Sep 2012 987 1000
29. T.J. Wang, J.M. Massaro, and D. Levy A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study JAMA 290 2003 1049 1056
30. H.-J. Lin, P.A. Wolf, and E.J. Benjamin Newly diagnosed atrial fibrillation and acute: stroke. The Framingham Study Stroke 26 1995 1527 1530
31. S.H. Hohnloser, H.J. Crijns, and M. van Eickels Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 Feb 12 2009 668 678
32. M.G. Whitbeck, R.J. Charnigo, and P. Khairy Increased mortality among patients taking digoxin-analysis from the AFFIRM study Eur Heart J 34 20 May 2013 1481 1488